戻る
Hua Medicine (Shanghai) Ltd. (02552.HK)価格
02552.HK 株価推移チャート
HUA MEDICINE-B (02552.HK)
Hua Medicine (Shanghai) Ltd.
HK$3.25
-4.69%
$-0.16
休場: Jan 16, 16:00:00 HKT
主要データ
前終値
$3.41
始値
$3.41
当日レンジ
$3.2 - $3.41
52週レンジ
$1.24 - $4.95
取引高
5.3M
平均取引高
3.5M
1株当たり利益(TTM)
1.21
配当利回り
--
時価総額
$3.2B
HUA MEDICINE-Bとは何ですか？
Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 285 full-time employees. The company went IPO on 2018-09-14. The firm is also engaged in the commercialization of HuaTangNing products. The Company’s main product pipeline dorzagliatin or HMS5552 is a glucokinase activator or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The firm mainly conducts its business in the domestic market.
